L ( period length )
three months ended
three months ended
 
loss before income tax
-57105
-2 802
 
adjustments to reconcile loss before income tax to cash flows
 
depreciation and amortisation
5272
4 430
 
impairment of intangible assets
1009
–
 
share of loss of equity accounted associates and joint ventures
10568
3 289
 
finance expenses
6757
962
 
expected credit loss allowance on trade receivables
247
122
 
expected credit loss allowance on restricted cash
3736
–
 
goodwill impairment
9256
–
 
net loss/-gain on financial assets and liabilities at fair value through profit or loss
4440
-1 299
 
impairment of equity accounted associates and joint ventures
12825
–
 
loss on remeasurement of financial instruments
150
174
 
net foreign exchange loss
1724
600
 
сash settled and equity settled share-based payments
1224
306
 
other non-cash items
88
-26
 
change in operating assets and liabilities
 
decrease in accounts receivable
4785
1 464
 
-increase/decrease in prepaid expenses and advances to suppliers
-884
28
 
increase in inventories and other assets
-83
-1 277
 
increase/-decrease in accounts payable and accrued expenses
8
-55
 
decrease in other non-current assets
1
271
 
increase in deferred revenue and customer advances
885
670
 
increase in financial assets at fair value through profit or loss
-464
-1 426
 
operating cash flows before interest and income taxes
4183
5 301
 
income tax paid
-334
-617
 
net cash provided by operating activities
2438
3 893
 
cash flows from investing activities
 
cash paid for property and equipment
-4255
-1 887
 
cash paid for intangible assets
-1370
-819
 
dividends received from equity accounted associates
–
461
 
loans issued
-5160
-3 836
 
cash paid for acquisitions of subsidiaries net of cash acquired
–
-192
 
cash paid for investments in equity accounted associates and joint ventures
-2000
-103
 
net cash used in investing activities
-12710
-6 376
 
cash flows from financing activities
 
payment of lease liabilities
-1115
-956
 
cash paid for non-controlling interests in subsidiaries
–
-24
 
dividends paid by subsidiaries to non-controlling shareholders
-36
-53
 
net cash provided by/-used in financing activities
7096
-1 686
 
net decrease in cash and cash equivalents
-3176
-4 169
 
effect of exchange differences on cash balances
2261
618
 
change in expected credit loss allowance on restricted cash
-3736
–
 
cash and cash equivalents at the beginning of the period
23737
39 297
 
cash and cash equivalents at the end of the period
19086
35 746